Literature DB >> 28038863

Association of remote ischemic peri-conditioning with reduced incidence of clinical heart failure after primary percutaneous coronary intervention.

Adetola Ladejobi1, Max Wayne1, Christian Martin-Gill2, Francis X Guyette2, Andrew D Althouse1, Michael S Sharbaugh1, Steven E Reis1, Clifton W Callaway2, John A Kellum3, A J Conrad Smith1, Catalin Toma1, Oladipupo Olafiranye4.   

Abstract

BACKGROUND: Clinical heart failure (HF) occurs frequently after ST-segment elevation myocardial infarction (STEMI), and is associated with increased mortality. We assessed the impact of remote ischemic peri-conditioning (RIPC) during inter-facility air medical transport of STEMI patients on clinical HF following primary percutaneous coronary intervention (pPCI).
METHODS: Data from Acute Coronary Treatment and Intervention Outcomes Network Registry®-Get With the Guidelines™ (ACTION Registry-GWTG) from two PCI-hospitals that are utilizing RIPC during inter-facility helicopter transport of STEMI patients for pPCI between March, 2013 and September, 2015 were used for this study. The analyses were limited to inter-facility STEMI patients transported by helicopter with LVEF <55% after pPCI. The outcome measures were occurrence of clinical HF and serum level of brain-type natriuretic peptide (BNP).
RESULTS: Out of the 150 STEMI patients in this analysis, 92 patients received RIPC and 58 did not. The RIPC and non-RIPC groups were generally similar in demographic and clinical characteristics except for lower incidence of cardiac arrest in the RIPC group (3/92 [3.3%] versus 13/58 [22.4%], p=0.002). STEMI patients who received RIPC were less likely to have in-hospital clinical HF compared to patients who did not receive RIPC (3/92 [3.3%] versus 7/58 [12.1%]; adjusted OR=0.22, 95% CI 0.05-0.92, p=0.038) after adjusting for baseline differences. In subgroup analysis, RIPC was associated with lower BNP (123 [interquartile range, 17.0-310] versus 319 [interquartile range, 106-552], p=0.029).
CONCLUSION: RIPC applied during inter-facility air transport of STEMI patients for pPCI is associated with reduced incidence of clinical HF and serum BNP.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute myocardial infarction; Brain-type natriuretic peptide; Heart failure; Remote ischemic conditioning

Mesh:

Year:  2016        PMID: 28038863      PMCID: PMC5350037          DOI: 10.1016/j.carrev.2016.12.004

Source DB:  PubMed          Journal:  Cardiovasc Revasc Med        ISSN: 1878-0938


  11 in total

1.  Feasibility of Remote Ischemic Peri-conditioning during Air Medical Transport of STEMI Patients.

Authors:  Christian Martin-Gill; Max Wayne; Francis X Guyette; Oladipupo Olafiranye; Catalin Toma
Journal:  Prehosp Emerg Care       Date:  2015-08-13       Impact factor: 3.077

2.  Incidence and predictors of heart failure following percutaneous coronary intervention in ST-segment elevation myocardial infarction: the HORIZONS-AMI trial.

Authors:  Damian J Kelly; Tony Gershlick; Bernhard Witzenbichler; Giulio Guagliumi; Martin Fahy; George Dangas; Roxana Mehran; Gregg W Stone
Journal:  Am Heart J       Date:  2011-10       Impact factor: 4.749

Review 3.  Conditioning of the heart: from pharmacological interventions to local and remote protection: possible implications for clinical practice.

Authors:  Shahar Lavi; Ronit Lavi
Journal:  Int J Cardiol       Date:  2010-09-06       Impact factor: 4.164

Review 4.  Epidemiology and management of heart failure and left ventricular systolic dysfunction in the aftermath of a myocardial infarction.

Authors:  J G F Cleland; A Torabi; N K Khan
Journal:  Heart       Date:  2005-05       Impact factor: 5.994

5.  Repeated remote ischemic conditioning attenuates left ventricular remodeling via exosome-mediated intercellular communication on chronic heart failure after myocardial infarction.

Authors:  Takehiro Yamaguchi; Yasukatsu Izumi; Yasuhiro Nakamura; Takanori Yamazaki; Masayuki Shiota; Soichi Sano; Masako Tanaka; Mayuko Osada-Oka; Kenei Shimada; Katuyuki Miura; Minoru Yoshiyama; Hiroshi Iwao
Journal:  Int J Cardiol       Date:  2014-10-30       Impact factor: 4.164

6.  Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion.

Authors:  K Przyklenk; B Bauer; M Ovize; R A Kloner; P Whittaker
Journal:  Circulation       Date:  1993-03       Impact factor: 29.690

7.  Circulating nitrite contributes to cardioprotection by remote ischemic preconditioning.

Authors:  Tienush Rassaf; Matthias Totzeck; Ulrike B Hendgen-Cotta; Sruti Shiva; Gerd Heusch; Malte Kelm
Journal:  Circ Res       Date:  2014-03-18       Impact factor: 17.367

8.  Heart failure after acute myocardial infarction: a lost battle in the war on heart failure?

Authors:  Pardeep S Jhund; John J V McMurray
Journal:  Circulation       Date:  2008-11-11       Impact factor: 29.690

9.  A call to ACTION (acute coronary treatment and intervention outcomes network): a national effort to promote timely clinical feedback and support continuous quality improvement for acute myocardial infarction.

Authors:  Eric D Peterson; Matthew T Roe; John S Rumsfeld; Richard E Shaw; Ralph G Brindis; Gregg C Fonarow; Christopher P Cannon
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2009-09

Review 10.  The annual global economic burden of heart failure.

Authors:  Christopher Cook; Graham Cole; Perviz Asaria; Richard Jabbour; Darrel P Francis
Journal:  Int J Cardiol       Date:  2013-12-22       Impact factor: 4.164

View more
  3 in total

Review 1.  Contrast-induced acute kidney injury in interventional cardiology: Emerging evidence and unifying mechanisms of protection by remote ischemic conditioning.

Authors:  Adebayo C Atanda; Oladipupo Olafiranye
Journal:  Cardiovasc Revasc Med       Date:  2017-06-06

2.  Effect of Remote Ischemic Conditioning in Patients With Takotsubo Syndrome After Acute Stroke: Study Protocol for a Randomized Controlled Trial.

Authors:  Tao Wang; Yueqiao Xu; Ning Wang; Meng Qi; Weitao Cheng; Xin Qu
Journal:  Front Neurol       Date:  2020-04-28       Impact factor: 4.003

Review 3.  Co-morbidities and co-medications as confounders of cardioprotection-Does it matter in the clinical setting?

Authors:  Petra Kleinbongard; Hans Erik Bøtker; Michel Ovize; Derek J Hausenloy; Gerd Heusch
Journal:  Br J Pharmacol       Date:  2020-01-03       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.